# Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children Aged 1~12 Years: A Single-armed Bridging Clinical Trial

> **NCT07473427** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Sinovac (Dalian) Vaccine Technology Co., Ltd.** · enrollment: 300 (estimated)

## Conditions studied

- Varicella (Chickenpox)
- Varicella Immunisation

## Interventions

- **BIOLOGICAL:** Varicella Vaccine

## Key facts

- **NCT ID:** NCT07473427
- **Lead sponsor:** Sinovac (Dalian) Vaccine Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07473427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07473427, "Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children Aged 1~12 Years: A Single-armed Bridging Clinical Trial". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07473427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*